Following the removal of CDC director Susan Monarez, President Trump appointed Jim O’Neill as the interim director, a move that sparked further controversy. O’Neill, a biotech investor with no medical background but ties to billionaire Peter Thiel, aligns with Health and Human Services Secretary Robert F. Kennedy Jr.’s agenda of restricting vaccine access. O’Neill’s history includes advocating for unproven COVID-19 treatments, downplaying vaccine dangers, and promoting libertarian views on healthcare. Critics, like Dr. Robert Steinbrook, have raised concerns about O’Neill’s conflicts of interest due to his financial links to several medical industry startups that could benefit from his position.
Read More
Following the departure of the CDC director, President Trump has appointed Jim O’Neill, a former investor and critic of health regulations, as acting director. O’Neill, who holds degrees in humanities, previously served as deputy to Health Secretary Robert F. Kennedy Jr. at HHS. His appointment comes amid controversies surrounding vaccine policies and follows the forced exit of the previous director. O’Neill’s background contrasts with the agency’s traditional medical and scientific leadership, raising questions about his independence and the influence of Secretary Kennedy.
Read More
According to an Associated Press source, a prominent advisor to Robert F. Kennedy Jr. is set to become the acting leader of the Centers for Disease Control and Prevention. This appointment follows the White House’s decision to remove the current CDC director. The specific reasons for the director’s removal and the rationale behind selecting Kennedy’s advisor remain undisclosed at this time. Further details regarding the transition are expected to be released soon.
Read More
John Q. Hosedrinker